Vancouver (1)

Bladder Cancer (1)

Durvalumab (1)

High-Risk Cancer (1)

Non-muscle Invasive (1)

Tremelimumab (1)

Recruiting (1)

phase 1/phase 2 (1)

University of British Columbia (1)

tremelimumab (1)

drug (1)

Other (1)

Interventional (1)

tremelimumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nov 3, 2021